-
Ticagrelor or Dual Therapy After Stents: Key Insights from the ULTIMATE-DAPT Study
- 2024/11/24
- 再生時間: 11 分
- ポッドキャスト
-
サマリー
あらすじ・解説
In this episode, we take an in-depth look at the groundbreaking ULTIMATE-DAPT clinical trial, which examines the safety and efficacy of using ticagrelor alone compared to combining it with aspirin for patients who have undergone stent placement after acute coronary syndromes. We’ll break down the study’s methodology, key findings, and their potential to reshape post-PCI treatment strategies by reducing bleeding risks while maintaining cardiovascular protection. Join us for a clear and insightful discussion on how this research could change the way heart patients are cared for worldwide. A must-listen for anyone interested in the latest advances in cardiology and patient-centered care.